SMTL ID : 4i85.1

Crystal structure of transthyretin in complex with CHF5074 at neutral pH

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.67 Å

Oligo State

homo-tetramer

Ligands

4 x H50: 1-(3',4'-dichloro-2-fluorobiphenyl-4-yl)cyclopropanecarboxylic acid(Non-covalent)

H50.1: 14 residues within 4Å: Chain A: K.15, L.17, A.108, L.110, S.117, T.118, T.119 Chain C: K.15, L.17, A.108, A.109, L.110, S.117 Ligands: H50.3 9 PLIP interactions: 5 interactions with chain C, 4 interactions with chain A Hydrophobic interactions: C:K.15, C:A.108, C:L.110, A:K.15, A:L.17, A:A.108 Salt bridges: C:K.15, A:K.15 Halogen bonds: C:A.109 H50.2: 13 residues within 4Å: Chain B: K.15, L.17, A.108, L.110, S.117, T.118, T.119 Chain D: K.15, L.17, A.108, L.110, S.117 Ligands: H50.4 4 PLIP interactions: 3 interactions with chain B, 1 interactions with chain D Hydrophobic interactions: B:L.17, B:A.108, D:K.15 Salt bridges: B:K.15 H50.3: 14 residues within 4Å: Chain A: K.15, L.17, A.108, A.109, L.110, S.117 Chain C: K.15, L.17, A.108, L.110, S.117, T.118, T.119 Ligands: H50.1 9 PLIP interactions: 4 interactions with chain C, 5 interactions with chain A Hydrophobic interactions: C:K.15, C:L.17, C:A.108, A:K.15, A:A.108, A:L.110 Salt bridges: C:K.15, A:K.15 Halogen bonds: A:A.109 H50.4: 13 residues within 4Å: Chain B: K.15, L.17, A.108, L.110, S.117 Chain D: K.15, L.17, A.108, L.110, S.117, T.118, T.119 Ligands: H50.2 4 PLIP interactions: 3 interactions with chain D, 1 interactions with chain B Hydrophobic interactions: D:L.17, D:A.108, B:K.15 Salt bridges: D:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zanotti, G. et al., Structural evidence for native state stabilization of a conformationally labile amyloidogenic transthyretin variant by fibrillogenesis inhibitors. Febs Lett. (2013)

Release Date

2013-06-19

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence